WAP
NUVB icon

Wealthcare Advisory Partners’s Nuvation Bio NUVB Stock Holding History

Wealthcare Advisory Partners’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-106,999
Closed -$459K – 1132
2026
Q1 		$459K Buy
106,999
+47
+0% +$262 0.01% 725
2025
Q4 		$958K Buy
+106,952
New +$663K 0.02% 527

Other funds holding NUVB

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
FWP
Firethorn Wealth Partners Augusta, Georgia $310M AUM 23.22% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Wealthcare Advisory Partners's NUVB Position: Q2 2026 in Review

Wealthcare Advisory Partners sold out of Nuvation Bio (NUVB) in Q2 2026, closing a stake of 106,999 shares — an estimated $459K sold.

Wealthcare Advisory Partners first reported a position in NUVB in Q4 2025 and held it in 2 quarters. The position peaked at $958K in Q4 2025. 13 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Wealthcare Advisory Partners reported no remaining Nuvation Bio position as of Q2 2026 after selling out during the quarter.
  • Wealthcare Advisory Partners sold 106,999 Nuvation Bio shares in Q2 2026, an estimated $459K.
  • Wealthcare Advisory Partners first reported a position in Nuvation Bio in Q4 2025 and held it in 2 quarters.
  • Wealthcare Advisory Partners's Nuvation Bio position peaked at $958K in Q4 2025.
  • 13 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2026, filed 9 Jul 2026.